These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 24887383)

  • 1. Autoimmune cytopenias after umbilical cord blood transplantation in adults with hematological malignancies: a single-center experience.
    Sanz J; Arango M; Carpio N; Montesinos P; Moscardó F; Martín G; López F; Jarque I; Lorenzo I; de la Rubia J; Solves P; Boluda B; Salazar C; Cañigral C; Sanz MA; Sanz GF
    Bone Marrow Transplant; 2014 Aug; 49(8):1084-8. PubMed ID: 24887383
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Autoimmune hemolysis and immune thrombocytopenic purpura after cord blood transplantation may be life-threatening and warrants early therapy with rituximab.
    Bhatt V; Shune L; Lauer E; Lubin M; Devlin SM; Scaradavou A; Parameswaran R; Perales MA; Ponce DM; Mantha S; Kernan NA; Barker JN
    Bone Marrow Transplant; 2016 Dec; 51(12):1579-1583. PubMed ID: 27643868
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical and serological characterization of autoimmune hemolytic anemia after allogeneic hematopoietic stem cell transplantation.
    Yang Z; Wu B; Zhou Y; Wang W; Chen S; Sun A; Wu D; Xu Y
    Chin Med J (Engl); 2014; 127(7):1235-8. PubMed ID: 24709172
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Autoimmune hemolytic anemia after allogeneic hematopoietic stem cell transplantation in adults: A southern China multicenter experience.
    Lv W; Qu H; Wu M; Fan Z; Huang F; Xu N; Xuan L; Lin R; Zhao K; Sun J; Lai Y; Xu Y; Liu Q
    Cancer Med; 2019 Nov; 8(15):6549-6558. PubMed ID: 31502764
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rituximab for immune cytopenia in adults: idiopathic thrombocytopenic purpura, autoimmune hemolytic anemia, and Evans syndrome.
    Shanafelt TD; Madueme HL; Wolf RC; Tefferi A
    Mayo Clin Proc; 2003 Nov; 78(11):1340-6. PubMed ID: 14601692
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy and safety of rituximab in auto-immune hemolytic anemia: A meta-analysis of 21 studies.
    Reynaud Q; Durieu I; Dutertre M; Ledochowski S; Durupt S; Michallet AS; Vital-Durand D; Lega JC
    Autoimmun Rev; 2015 Apr; 14(4):304-13. PubMed ID: 25497766
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Addition of rituximab to standard therapy improves response rate and progression-free survival in relapsed or refractory thrombotic thrombocytopenic purpura and autoimmune haemolytic anaemia.
    Heidel F; Lipka DB; von Auer C; Huber C; Scharrer I; Hess G
    Thromb Haemost; 2007 Feb; 97(2):228-33. PubMed ID: 17264951
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rituximab-cyclophosphamide-dexamethasone combination in the management of autoimmune cytopenias associated with chronic lymphocytic leukemia.
    Rossignol J; Michallet AS; Oberic L; Picard M; Garon A; Willekens C; Dulery R; Leleu X; Cazin B; Ysebaert L
    Leukemia; 2011 Mar; 25(3):473-8. PubMed ID: 21127498
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Posttransplant autoimmune hemolytic anemia and other autoimmune cytopenias are increased in very young infants undergoing unrelated donor umbilical cord blood transplantation.
    Page KM; Mendizabal AM; Prasad VK; Martin PL; Parikh S; Wood S; Sempowski GD; Szabolcs P; Kurtzberg J
    Biol Blood Marrow Transplant; 2008 Oct; 14(10):1108-1117. PubMed ID: 18804040
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rituximab is effective in the management of refractory autoimmune cytopenias occurring after allogeneic stem cell transplantation.
    Raj K; Narayanan S; Augustson B; Ho A; Mehta P; Duncan N; Tauro S; Mahendra P; Craddock C; Mufti G
    Bone Marrow Transplant; 2005 Feb; 35(3):299-301. PubMed ID: 15568036
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rituximab in auto-immune haemolytic anaemia and immune thrombocytopenic purpura: a Belgian retrospective multicentric study.
    Dierickx D; Verhoef G; Van Hoof A; Mineur P; Roest A; Triffet A; Kentos A; Pierre P; Boulet D; Bries G; Lê PQ; Janssens A; Delannoy A
    J Intern Med; 2009 Nov; 266(5):484-91. PubMed ID: 19549092
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Low-dose rituximab and alemtuzumab combination therapy for patients with steroid-refractory autoimmune cytopenias.
    Gómez-Almaguer D; Solano-Genesta M; Tarín-Arzaga L; Herrera-Garza JL; Cantú-Rodríguez OG; Gutiérrez-Aguirre CH; Jaime-Pérez JC
    Blood; 2010 Dec; 116(23):4783-5. PubMed ID: 20841509
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Autoimmune hemolytic anemia: diagnosis and management].
    Philippe P
    Presse Med; 2007 Dec; 36(12 Pt 3):1959-69. PubMed ID: 17481848
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Autoimmune hemolytic anemia following allogeneic hematopoietic stem cell transplantation in adult patients.
    Sanz J; Arriaga F; Montesinos P; Ortí G; Lorenzo I; Cantero S; Puig N; Moscardó F; de la Rubia J; Sanz G; Sanz MA
    Bone Marrow Transplant; 2007 May; 39(9):555-61. PubMed ID: 17351645
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rituximab therapy in a patient with autoimmune hemolytic anemia and immune thrombocytopenia associated with chronic lymphocytic leukemia.
    Aleem A
    Ann Saudi Med; 2008; 28(5):382-5. PubMed ID: 18779631
    [No Abstract]   [Full Text] [Related]  

  • 16. Expanded utilization of rituximab in paediatric cardiac transplant patients.
    Kiskaddon AL; Landmesser K; Carapellucci J; Wisotzkey B; Asante-Korang A
    J Clin Pharm Ther; 2021 Jun; 46(3):762-766. PubMed ID: 33393702
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rituximab in the treatment of refractory autoimmune cytopenias in adults.
    Narat S; Gandla J; Hoffbrand AV; Hughes RG; Mehta AB
    Haematologica; 2005 Sep; 90(9):1273-4. PubMed ID: 16154853
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sustained response to low-dose rituximab in idiopathic autoimmune hemolytic anemia.
    Barcellini W; Zaja F; Zaninoni A; Imperiali FG; Di Bona E; Fattizzo B; Consonni D; Cortelezzi A; Zanella A
    Eur J Haematol; 2013 Dec; 91(6):546-51. PubMed ID: 24033754
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy and safety of rituximab for systemic lupus erythematosus-associated immune cytopenias: A multicenter retrospective cohort study of 71 adults.
    Serris A; Amoura Z; Canouï-Poitrine F; Terrier B; Hachulla E; Costedoat-Chalumeau N; Papo T; Lambotte O; Saadoun D; Hié M; Blanche P; Lioger B; Gottenberg JE; Godeau B; Michel M
    Am J Hematol; 2018 Mar; 93(3):424-429. PubMed ID: 29247540
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The spectrum of Evans syndrome in adults: new insight into the disease based on the analysis of 68 cases.
    Michel M; Chanet V; Dechartres A; Morin AS; Piette JC; Cirasino L; Emilia G; Zaja F; Ruggeri M; Andrès E; Bierling P; Godeau B; Rodeghiero F
    Blood; 2009 Oct; 114(15):3167-72. PubMed ID: 19638626
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.